Barbara Rita Alevriadou PhD

Barbara Rita Alevriadou

Barbara Rita Alevriadou
PhD

SUNY Empire Innovation Professor in Biomedical Engineering

Department of Biomedical Engineering

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Cardiopulmonary physiology; Cardiovascular Disease; Metabolism; Molecular and Cellular Biology; Molecular Basis of Disease; Research Lab; Signal Transduction; Vascular Medicine

Contact Information
301 Bonner Hall
Department of Biomedical Engineering
University at Buffalo
Buffalo, New York 14260-1900
Phone: 716-645-8499
alevri@buffalo.edu



Professional Summary:

Dr. Alevriadou received her BS in Chemical Engineering from the Aristotle University, Thessaloniki, Greece, in 1986 and her PhD in Chemical Engineering (Bioengineering & Biosciences Institute) from Rice University, Houston, TX in 1992. Following postdoctoral training in the Department of Molecular & Experimental Medicine at Scripps Research Institute, La Jolla, CA, she joined the BME Department at Johns Hopkins University, Baltimore, MD, as Assistant Professor. In 2003, she joined the BME Center (BME Department, since 2008) and Davis Heart & Lung Research Institute of The Ohio State University as Associate Professor of BME and Internal Medicine, Cardiovascular Medicine. In 2019, she joined the University at Buffalo - The State University of New York (SUNY-Buffalo) as Empire Innovation Professor in BME. Her research on vascular endothelial mechanobiology, intracellular signaling, metabolism, mitochondrial function, and extracellular vesicles, is/has been supported by the National Institutes of Health (NIH) and the American Heart Association (AHA). Dr. Alevriadou is a member of the AHA, the Biomedical Engineering Society (BMES) (1994-present; elected member on the Board of Directors, 2014-2017; elevated to BMES Fellow, 2024-present), the North American Vascular Biology Organization (NAVBO), the Society for Redox Biology & Medicine (SfRBM), and the American Physiological Society (APS). She regularly reviews for federal/local funding agencies (NIH, NSF, AHA) and biomedical and cardiovascular journals. She serves on the Editorial Board of the American Journal of Physiology-Cell Physiology (2002-2019 and 2022-present; Associate Editor, 2019-2021), NAVBO Alert (Contributing Editor, 2022-present), Physiological Reports (2023-present), and Nature-Scientific Reports (2023-present).

Education and Training:

  • The Scripps Research Institute, Department of Molecular and Experimental Medicine, La Jolla, CA (1993)
  • Rice University, Houston, TX (1992)
  • Rice University, Houston, TX (1989)
  • Aristotle University, Thessaloniki, Greece (1986)

Employment:

  • Professor, Adjunct, Chemical and Biological Engineering, University at Buffalo - The State University of New York, Buffalo, NY (2021-present)
  • Professor, Empire Innovation Professor in Biomedical Engineering, Biomedical Engineering, University at Buffalo - The State University of New York, Buffalo, NY (2019-present)
  • Affiliate Faculty, Davis Heart and Lung Research Institute and the Center for Regenerative Medicine & Cell-Based Therapies, The Ohio State University Wexner Medical Center, Columbus, OH (2003–2019)
  • Associate Professor of Biomedical Engineering, Departments of Biomedical Engineering and Internal Medicine (Cardiovascular Medicine), The Ohio State University, Columbus, OH (2003–2019)
  • Affiliate Faculty in Chemical and Biomolecular Engineering, Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD (1993–2003)
  • Assistant Professor of Biomedical Engineering, Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD (1993–2003)

Awards and Honors:

  • Vasculata 2026 Conference Chair (with co-Chairs Drs. Angela Glading and Marc Halterman) (2026)
  • Induction to BMES Fellow (2024)
  • Chair, Mitochondrial Biology Symposium (2021)
  • Empire Innovation Professor and PRODiG Awardee (2019)
  • Associate Editor of the American Journal of Physiology – Cell Physiology (2019)
  • American Physiological Society (APS) STAR Reviewer (2016)
  • Certificate of Recognition for dedication and volunteerism, Society for Redox Biology and Medicine (2016)
  • Board of Directors, Biomedical Engineering Society (2014)
  • Chair, The Ohio State University College of Engineering Committee on the Responsible Conduct of Research (2013)
  • Nominee for the WM Keck Foundation Research Award, The Ohio State University (2011)
  • Co-Chair, Cardiovascular Track, BMES 2009 Annual Meeting (2009)
  • Director's Executive Cabinet, Davis Heart & Lung Research Institute, The Ohio State University (2008)
  • Editorial Board, The American Journal of Physiology - Cell Physiology (2002)
  • Graduate Fellowship, Robert A. Welch Foundation, Rice University (1992)

Research Expertise:

  • MOLECULAR BASIS OF CARDIOVASCULAR DISEASE: Understanding the role of hemodynamics and chemical agonists in regulating the endothelial phenotype and initiating atherosclerosis/coronary artery disease and other cardiovascular diseases/conditions (hypertension, cardiac ischemia/reperfusion injury, heart failure, etc.)
  • VASCULAR ENDOTHELIAL (DYS)FUNCTION: Assessing the cell's calcium- and reactive oxygen species (including nitric oxide)-mediated signaling, mitochondrial function and metabolism, gene expression/protein synthesis, inflammation, apoptosis, extracellular vesicles (EVs), horizontal transfer of EV cargo, and EV paracrine effects
  • VASCULAR MECHANOBIOLOGY / MECHANOTRANSDUCTION: Effects of hemodynamic forces (e.g., shear stress, tensile stress) and/or oxygen tension on the vascular endothelium; Signal transduction due to changes in the cell‘s mechanochemical environment

Research Centers:

  • Center for Research in Cardiovascular Medicine

UB 2020 Strategic Strengths:

  • Health and Wellness Across the Lifespan
  • Molecular Recognition in Biological Systems and Bioinformatics

Grants and Sponsored Research:

  • July 2024–June 2026
    Mitochondria-Containing Endothelial-Derived Extracellular Vesicles in MELAS. Private Foundation grant
    The Foundation for a Cure for Mitochondrial Disease
    Role: Principal Investigator
  • August 2018–June 2023
    Control of Endothelial Mechanotransduction by the Mitochondrial Ca2+ Uniporter: Implications for Atherosclerosis. NIH R01 grant
    NIH/NHLBI
    Role: Principal Investigator
  • January 2016–June 2018
    Redox Regulation of Autophagy in Postischemic Vascular Endothelial Cells. AHA Grant-In-Aid
    American Heart Association
    Role: Principal Investigator
  • June 2011–May 2013
    Emerging Functions of Mitochondrial Fission in Postischemic Endothelial Cells. NIH R21 grant
    NIH/NHLBI
    Role: Principal Investigator
  • January 2008–December 2009
    Mechanoregulation of Endothelial Mitochondrial Function. NIH R21 grant
    NIH/NHLBI
    Role: Principal Investigator
  • December 2001–February 2006
    Reperfusion-Induced Endothelial Cell Dysfunction. NIH R01 grant
    NIH/NHLBI
    Role: Principal Investigator

Journal Articles:

See all (23 more)

Professional Memberships:

  • American Physiological Society (APS) (Member, Cell and Molecular Physiology Section); Member (2020–present)
  • American Heart Association (AHA) (Member, Council on Basic Cardiovascular Sciences) (2010–present)
  • Society for Redox Biology and Medicine (SFRBM) (Women in Science Mentoring Committee, 2005-present) (1995–present)
  • North American Vascular Biology Organization (NAVBO) (Founding Member) (1994–present)
  • Biomedical Engineering Society (BMES) (Board of Directors 2014-17; Student Affairs and Diversity Committees 2014-18; International Affairs Committee 2018-present) (1994–present)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

301 Bonner Hall
Department of Biomedical Engineering
University at Buffalo
Buffalo, New York 14260-1900
Phone: 716-645-8499
alevri@buffalo.edu